| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteoglycans | 98 | 2018 | 345 | 8.160 |
Why?
|
| Arthritis, Experimental | 50 | 2019 | 132 | 7.610 |
Why?
|
| Arthritis, Rheumatoid | 61 | 2020 | 365 | 6.100 |
Why?
|
| Extracellular Matrix Proteins | 32 | 2010 | 131 | 4.620 |
Why?
|
| Mice | 128 | 2020 | 1683 | 3.770 |
Why?
|
| Mice, Inbred BALB C | 94 | 2019 | 270 | 3.680 |
Why?
|
| T-Lymphocytes | 40 | 2019 | 223 | 3.460 |
Why?
|
| Arthritis | 32 | 2011 | 105 | 3.260 |
Why?
|
| Animals | 174 | 2020 | 4723 | 3.120 |
Why?
|
| Aggrecans | 42 | 2019 | 157 | 2.890 |
Why?
|
| Disease Models, Animal | 52 | 2019 | 782 | 2.590 |
Why?
|
| Cartilage, Articular | 43 | 2016 | 550 | 2.570 |
Why?
|
| Lectins, C-Type | 31 | 2016 | 111 | 2.320 |
Why?
|
| Cytokines | 37 | 2019 | 351 | 2.210 |
Why?
|
| Lymphocyte Activation | 25 | 2019 | 217 | 1.950 |
Why?
|
| Spondylitis, Ankylosing | 15 | 2017 | 46 | 1.760 |
Why?
|
| Epitopes, T-Lymphocyte | 13 | 2016 | 32 | 1.640 |
Why?
|
| Genetic Predisposition to Disease | 18 | 2013 | 464 | 1.590 |
Why?
|
| Cartilage | 31 | 2018 | 159 | 1.510 |
Why?
|
| Epitopes | 23 | 2017 | 88 | 1.510 |
Why?
|
| Autoimmune Diseases | 12 | 2019 | 63 | 1.460 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 4 | 2020 | 16 | 1.320 |
Why?
|
| Titanium | 17 | 2007 | 196 | 1.230 |
Why?
|
| Osteoblasts | 11 | 2005 | 63 | 1.230 |
Why?
|
| Synovial Membrane | 14 | 2012 | 84 | 1.190 |
Why?
|
| T-Lymphocyte Subsets | 9 | 2014 | 89 | 1.180 |
Why?
|
| Autoantibodies | 16 | 2019 | 103 | 1.180 |
Why?
|
| B-Lymphocytes | 13 | 2019 | 89 | 1.170 |
Why?
|
| Quantitative Trait Loci | 7 | 2012 | 61 | 1.110 |
Why?
|
| Fibroblasts | 10 | 2008 | 93 | 1.090 |
Why?
|
| Female | 99 | 2019 | 16983 | 1.060 |
Why?
|
| Humans | 129 | 2019 | 30997 | 1.050 |
Why?
|
| Neutrophils | 6 | 2016 | 120 | 1.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 11 | 2014 | 234 | 0.970 |
Why?
|
| Cells, Cultured | 30 | 2019 | 686 | 0.940 |
Why?
|
| Bone Resorption | 10 | 2008 | 97 | 0.940 |
Why?
|
| Th1 Cells | 8 | 2013 | 34 | 0.930 |
Why?
|
| Pyoderma Gangrenosum | 2 | 2016 | 6 | 0.920 |
Why?
|
| Cell Adhesion Molecules | 9 | 2012 | 40 | 0.910 |
Why?
|
| Mice, Inbred DBA | 20 | 2013 | 51 | 0.880 |
Why?
|
| Interleukin-17 | 8 | 2016 | 30 | 0.850 |
Why?
|
| Molecular Sequence Data | 20 | 2012 | 247 | 0.840 |
Why?
|
| Macrophages | 5 | 2010 | 137 | 0.830 |
Why?
|
| Major Histocompatibility Complex | 6 | 2016 | 14 | 0.810 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2016 | 226 | 0.800 |
Why?
|
| Immunity, Innate | 7 | 2016 | 97 | 0.780 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2019 | 80 | 0.780 |
Why?
|
| Mice, Transgenic | 18 | 2016 | 261 | 0.760 |
Why?
|
| Apoptosis | 7 | 2019 | 260 | 0.750 |
Why?
|
| Osteolysis | 7 | 2006 | 147 | 0.740 |
Why?
|
| Alternative Splicing | 4 | 2011 | 24 | 0.730 |
Why?
|
| Skin Diseases | 2 | 2011 | 29 | 0.730 |
Why?
|
| Signal Transduction | 9 | 2020 | 498 | 0.720 |
Why?
|
| Chromosomes, Mammalian | 2 | 2012 | 5 | 0.720 |
Why?
|
| Adoptive Transfer | 10 | 2014 | 46 | 0.710 |
Why?
|
| Citrulline | 3 | 2016 | 12 | 0.690 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2012 | 33 | 0.690 |
Why?
|
| Mutation | 6 | 2016 | 409 | 0.690 |
Why?
|
| Immunization | 15 | 2013 | 47 | 0.680 |
Why?
|
| Mice, SCID | 13 | 2014 | 58 | 0.680 |
Why?
|
| Joints | 12 | 2012 | 99 | 0.660 |
Why?
|
| Joint Prosthesis | 4 | 2007 | 79 | 0.650 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 165 | 0.650 |
Why?
|
| Gene Expression | 8 | 2013 | 239 | 0.650 |
Why?
|
| Interleukin-6 | 6 | 2008 | 112 | 0.640 |
Why?
|
| Interleukin-4 | 7 | 2010 | 35 | 0.640 |
Why?
|
| Interferon-gamma | 14 | 2014 | 111 | 0.640 |
Why?
|
| Amino Acid Sequence | 16 | 2016 | 195 | 0.620 |
Why?
|
| Hybridomas | 8 | 2005 | 19 | 0.620 |
Why?
|
| Interleukin-1beta | 3 | 2016 | 61 | 0.620 |
Why?
|
| Peptide Fragments | 9 | 2013 | 98 | 0.610 |
Why?
|
| Lymphocytes | 10 | 2006 | 111 | 0.600 |
Why?
|
| Antigen Presentation | 7 | 2015 | 22 | 0.600 |
Why?
|
| Biocompatible Materials | 5 | 2001 | 104 | 0.590 |
Why?
|
| RNA, Messenger | 15 | 2009 | 329 | 0.590 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 8 | 2010 | 29 | 0.580 |
Why?
|
| Osteoarthritis | 11 | 2016 | 384 | 0.570 |
Why?
|
| Collagen | 11 | 2002 | 103 | 0.560 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 78 | 0.550 |
Why?
|
| Mice, Knockout | 24 | 2019 | 323 | 0.550 |
Why?
|
| Phenotype | 7 | 2012 | 379 | 0.540 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2012 | 10 | 0.540 |
Why?
|
| Sweet Syndrome | 1 | 2016 | 4 | 0.540 |
Why?
|
| Antigens | 12 | 2013 | 27 | 0.530 |
Why?
|
| Hyaluronan Receptors | 8 | 2008 | 33 | 0.520 |
Why?
|
| Male | 47 | 2014 | 16445 | 0.520 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2017 | 103 | 0.510 |
Why?
|
| Autoantigens | 8 | 2016 | 39 | 0.510 |
Why?
|
| Blotting, Western | 9 | 2016 | 178 | 0.500 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2020 | 57 | 0.470 |
Why?
|
| Cell Proliferation | 10 | 2016 | 204 | 0.460 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2012 | 59 | 0.460 |
Why?
|
| Phosphorylation | 4 | 2013 | 164 | 0.440 |
Why?
|
| NF-kappa B | 5 | 2006 | 110 | 0.440 |
Why?
|
| Cytoskeletal Proteins | 2 | 2011 | 25 | 0.440 |
Why?
|
| Intervertebral Disc | 4 | 2005 | 218 | 0.440 |
Why?
|
| Cattle | 19 | 2004 | 219 | 0.430 |
Why?
|
| Disease Progression | 10 | 2019 | 830 | 0.420 |
Why?
|
| Gene Expression Regulation | 6 | 2007 | 287 | 0.420 |
Why?
|
| Monocytes | 5 | 2003 | 115 | 0.420 |
Why?
|
| Autoimmunity | 5 | 2019 | 19 | 0.410 |
Why?
|
| Adult | 25 | 2016 | 8931 | 0.410 |
Why?
|
| HLA-DQ Antigens | 3 | 2016 | 7 | 0.400 |
Why?
|
| Antibodies, Monoclonal | 13 | 2008 | 271 | 0.400 |
Why?
|
| Spleen | 13 | 2019 | 55 | 0.400 |
Why?
|
| Genetic Loci | 1 | 2012 | 65 | 0.390 |
Why?
|
| Proteins | 4 | 2003 | 73 | 0.390 |
Why?
|
| Homeostasis | 1 | 2012 | 86 | 0.390 |
Why?
|
| Carrier Proteins | 6 | 2003 | 103 | 0.390 |
Why?
|
| Hyaluronic Acid | 7 | 2012 | 102 | 0.390 |
Why?
|
| Species Specificity | 11 | 2005 | 73 | 0.390 |
Why?
|
| Osteoprotegerin | 2 | 2008 | 7 | 0.390 |
Why?
|
| RANK Ligand | 2 | 2008 | 7 | 0.390 |
Why?
|
| Crosses, Genetic | 5 | 2008 | 15 | 0.390 |
Why?
|
| Inflammation Mediators | 6 | 2010 | 82 | 0.390 |
Why?
|
| Glycosaminoglycans | 7 | 2011 | 53 | 0.380 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2011 | 2 | 0.380 |
Why?
|
| Peptides | 2 | 2018 | 97 | 0.380 |
Why?
|
| Particle Size | 11 | 2007 | 71 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 11 | 2016 | 466 | 0.380 |
Why?
|
| Base Sequence | 10 | 2011 | 134 | 0.370 |
Why?
|
| Synovial Fluid | 5 | 2014 | 127 | 0.370 |
Why?
|
| Dogs | 21 | 2004 | 263 | 0.370 |
Why?
|
| Glycoproteins | 8 | 2012 | 59 | 0.360 |
Why?
|
| Cell Death | 1 | 2010 | 61 | 0.360 |
Why?
|
| Streptococcus pyogenes | 1 | 2010 | 5 | 0.360 |
Why?
|
| Immunomodulation | 1 | 2010 | 9 | 0.360 |
Why?
|
| Disease Susceptibility | 5 | 2012 | 86 | 0.350 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 13 | 0.350 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2009 | 24 | 0.350 |
Why?
|
| Phagocytosis | 9 | 2007 | 52 | 0.350 |
Why?
|
| Antigen-Presenting Cells | 5 | 2013 | 16 | 0.340 |
Why?
|
| Hip Prosthesis | 6 | 1997 | 578 | 0.340 |
Why?
|
| Penetrance | 1 | 2009 | 3 | 0.330 |
Why?
|
| Th2 Cells | 5 | 2005 | 28 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 158 | 0.330 |
Why?
|
| Spondylarthropathies | 2 | 2005 | 8 | 0.320 |
Why?
|
| Models, Immunological | 1 | 2008 | 9 | 0.310 |
Why?
|
| Procollagen | 4 | 2004 | 8 | 0.310 |
Why?
|
| Adjuvants, Immunologic | 3 | 2004 | 29 | 0.300 |
Why?
|
| Antibody Formation | 9 | 2012 | 38 | 0.300 |
Why?
|
| Chromosome Mapping | 6 | 2012 | 53 | 0.300 |
Why?
|
| Aging | 5 | 2010 | 1727 | 0.300 |
Why?
|
| Polystyrenes | 4 | 1997 | 4 | 0.300 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 5 | 0.300 |
Why?
|
| Spine | 4 | 2018 | 132 | 0.300 |
Why?
|
| Transcription, Genetic | 5 | 2003 | 107 | 0.300 |
Why?
|
| Immunohistochemistry | 8 | 2016 | 430 | 0.300 |
Why?
|
| HLA-DR4 Antigen | 2 | 2004 | 4 | 0.290 |
Why?
|
| Down-Regulation | 4 | 2018 | 113 | 0.290 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 64 | 0.290 |
Why?
|
| Middle Aged | 21 | 2014 | 10195 | 0.290 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2012 | 21 | 0.280 |
Why?
|
| Mice, Inbred C3H | 7 | 2007 | 36 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2016 | 135 | 0.280 |
Why?
|
| CD28 Antigens | 2 | 2004 | 18 | 0.270 |
Why?
|
| Aged | 19 | 2012 | 10048 | 0.270 |
Why?
|
| Th17 Cells | 3 | 2016 | 29 | 0.270 |
Why?
|
| Membrane Glycoproteins | 4 | 2003 | 107 | 0.260 |
Why?
|
| Up-Regulation | 4 | 2016 | 177 | 0.260 |
Why?
|
| DNA Methylation | 2 | 2019 | 134 | 0.260 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2008 | 18 | 0.260 |
Why?
|
| Exons | 4 | 2011 | 38 | 0.260 |
Why?
|
| Flow Cytometry | 7 | 2019 | 204 | 0.260 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2016 | 48 | 0.250 |
Why?
|
| Cell Division | 8 | 2004 | 113 | 0.250 |
Why?
|
| Antibodies | 9 | 2008 | 67 | 0.250 |
Why?
|
| Osteogenesis | 4 | 2016 | 107 | 0.250 |
Why?
|
| Cell Survival | 6 | 2004 | 164 | 0.250 |
Why?
|
| Epidermal Growth Factor | 2 | 1996 | 33 | 0.250 |
Why?
|
| Prosthesis Failure | 7 | 2006 | 539 | 0.250 |
Why?
|
| Sacroiliac Joint | 1 | 2005 | 10 | 0.250 |
Why?
|
| Leukocytes | 7 | 2012 | 46 | 0.250 |
Why?
|
| Antibody Specificity | 6 | 2016 | 54 | 0.240 |
Why?
|
| Cell Line | 11 | 2018 | 305 | 0.240 |
Why?
|
| Inflammation | 9 | 2016 | 362 | 0.240 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2002 | 15 | 0.240 |
Why?
|
| Calcitriol | 1 | 2004 | 6 | 0.240 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2002 | 10 | 0.240 |
Why?
|
| Recombinant Proteins | 6 | 2012 | 254 | 0.240 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2004 | 3 | 0.240 |
Why?
|
| Growth Substances | 2 | 2001 | 39 | 0.240 |
Why?
|
| Diphosphonates | 1 | 2004 | 16 | 0.230 |
Why?
|
| Keratan Sulfate | 3 | 1993 | 27 | 0.230 |
Why?
|
| Culture Media, Conditioned | 6 | 2006 | 31 | 0.230 |
Why?
|
| Bone Marrow Cells | 3 | 2016 | 59 | 0.230 |
Why?
|
| Arthroplasty, Replacement | 2 | 2007 | 150 | 0.230 |
Why?
|
| Myeloid Cells | 2 | 2014 | 16 | 0.230 |
Why?
|
| Sequence Alignment | 1 | 2003 | 22 | 0.230 |
Why?
|
| Metals | 4 | 2002 | 154 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 5 | 2011 | 81 | 0.220 |
Why?
|
| Cell Movement | 9 | 2012 | 105 | 0.220 |
Why?
|
| Cluster Analysis | 1 | 2003 | 53 | 0.220 |
Why?
|
| Knee Prosthesis | 1 | 2006 | 240 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 81 | 0.220 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2003 | 1 | 0.220 |
Why?
|
| Genetic Testing | 1 | 2003 | 65 | 0.220 |
Why?
|
| Polymorphism, Genetic | 4 | 2013 | 75 | 0.220 |
Why?
|
| Prostheses and Implants | 2 | 2006 | 167 | 0.220 |
Why?
|
| Immunity, Cellular | 6 | 2012 | 63 | 0.210 |
Why?
|
| Dendritic Cells | 3 | 2013 | 59 | 0.210 |
Why?
|
| Mice, Inbred Strains | 4 | 2010 | 28 | 0.210 |
Why?
|
| Antigens, CD | 2 | 2004 | 101 | 0.210 |
Why?
|
| Ligases | 1 | 2002 | 9 | 0.210 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 17 | 0.210 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 144 | 0.210 |
Why?
|
| Ubiquitin | 1 | 2002 | 26 | 0.210 |
Why?
|
| Phosphoproteins | 1 | 2002 | 30 | 0.210 |
Why?
|
| Arthritis, Psoriatic | 1 | 2002 | 19 | 0.210 |
Why?
|
| L-Selectin | 4 | 2006 | 17 | 0.210 |
Why?
|
| fas Receptor | 2 | 2003 | 11 | 0.200 |
Why?
|
| Cell Differentiation | 3 | 2016 | 152 | 0.200 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2002 | 6 | 0.200 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 7 | 0.200 |
Why?
|
| Chemokines | 3 | 2007 | 29 | 0.200 |
Why?
|
| Spondylarthritis | 2 | 2012 | 5 | 0.200 |
Why?
|
| Genetic Therapy | 1 | 2003 | 93 | 0.200 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 1133 | 0.200 |
Why?
|
| Genetic Linkage | 5 | 2009 | 67 | 0.200 |
Why?
|
| Thymus Gland | 3 | 2000 | 26 | 0.200 |
Why?
|
| Granulocytes | 4 | 2008 | 23 | 0.200 |
Why?
|
| Genetic Markers | 4 | 2015 | 59 | 0.190 |
Why?
|
| Interleukin-1 | 7 | 2001 | 79 | 0.190 |
Why?
|
| Cross Reactions | 7 | 2016 | 26 | 0.190 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 10 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 2 | 2016 | 63 | 0.190 |
Why?
|
| Skin | 3 | 2016 | 124 | 0.190 |
Why?
|
| Algorithms | 1 | 2003 | 414 | 0.180 |
Why?
|
| Fetus | 4 | 1998 | 59 | 0.180 |
Why?
|
| Interleukin-2 | 5 | 2007 | 69 | 0.180 |
Why?
|
| Mice, Congenic | 2 | 2012 | 4 | 0.180 |
Why?
|
| Joint Diseases | 2 | 1993 | 114 | 0.180 |
Why?
|
| Hindlimb | 4 | 2018 | 25 | 0.180 |
Why?
|
| Edema | 3 | 2001 | 40 | 0.180 |
Why?
|
| Uveitis, Anterior | 2 | 2012 | 5 | 0.180 |
Why?
|
| Mitochondria | 1 | 2000 | 87 | 0.170 |
Why?
|
| Vaccines | 2 | 2017 | 13 | 0.170 |
Why?
|
| Kinetics | 7 | 2012 | 226 | 0.170 |
Why?
|
| Immunophenotyping | 5 | 2004 | 86 | 0.170 |
Why?
|
| Aged, 80 and over | 7 | 2011 | 5189 | 0.170 |
Why?
|
| Dinoprostone | 5 | 2001 | 26 | 0.170 |
Why?
|
| Rats | 10 | 2013 | 873 | 0.170 |
Why?
|
| DNA | 8 | 2005 | 124 | 0.170 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2019 | 1 | 0.170 |
Why?
|
| Azacitidine | 1 | 2019 | 12 | 0.170 |
Why?
|
| Immune Tolerance | 2 | 2014 | 21 | 0.170 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 138 | 0.170 |
Why?
|
| Orthopedic Procedures | 1 | 2003 | 329 | 0.170 |
Why?
|
| Immunization, Passive | 3 | 1995 | 20 | 0.160 |
Why?
|
| Sensory System Agents | 1 | 2018 | 4 | 0.160 |
Why?
|
| Capsaicin | 1 | 2018 | 11 | 0.160 |
Why?
|
| Immunoglobulin G | 8 | 2019 | 130 | 0.160 |
Why?
|
| Sensory Thresholds | 1 | 2018 | 23 | 0.160 |
Why?
|
| Receptors, Interleukin-1 Type II | 1 | 2018 | 1 | 0.160 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2010 | 7 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 6 | 2002 | 149 | 0.160 |
Why?
|
| Fingolimod Hydrochloride | 2 | 2016 | 4 | 0.160 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2006 | 688 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2018 | 30 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2005 | 46 | 0.160 |
Why?
|
| Incidence | 4 | 2005 | 785 | 0.160 |
Why?
|
| Time Factors | 8 | 2005 | 1672 | 0.150 |
Why?
|
| Lymphocyte Depletion | 2 | 2011 | 6 | 0.150 |
Why?
|
| Lymph Nodes | 4 | 2013 | 74 | 0.150 |
Why?
|
| Homozygote | 2 | 2011 | 24 | 0.150 |
Why?
|
| Acute Disease | 3 | 2004 | 231 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2011 | 43 | 0.150 |
Why?
|
| Immunoglobulins | 2 | 2011 | 31 | 0.150 |
Why?
|
| Methylmethacrylates | 2 | 1994 | 2 | 0.140 |
Why?
|
| Injections, Intraperitoneal | 3 | 2001 | 13 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2016 | 7 | 0.140 |
Why?
|
| Complex Mixtures | 1 | 2016 | 4 | 0.130 |
Why?
|
| Tissue Extracts | 1 | 2016 | 12 | 0.130 |
Why?
|
| In Situ Hybridization | 2 | 2009 | 52 | 0.130 |
Why?
|
| Arginine | 1 | 2016 | 19 | 0.130 |
Why?
|
| Myocarditis | 1 | 2016 | 11 | 0.130 |
Why?
|
| Swine | 5 | 2004 | 92 | 0.130 |
Why?
|
| Drug Combinations | 2 | 2007 | 68 | 0.130 |
Why?
|
| Interleukin-10 | 2 | 2009 | 39 | 0.130 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 29 | 0.130 |
Why?
|
| Endopeptidases | 2 | 2011 | 30 | 0.130 |
Why?
|
| Interleukin-8 | 3 | 2006 | 32 | 0.130 |
Why?
|
| Heart | 1 | 2016 | 96 | 0.130 |
Why?
|
| Ligands | 4 | 2003 | 57 | 0.130 |
Why?
|
| Genome | 3 | 2012 | 15 | 0.130 |
Why?
|
| DNA, Complementary | 2 | 2011 | 28 | 0.130 |
Why?
|
| Foreign-Body Reaction | 1 | 1995 | 28 | 0.130 |
Why?
|
| Lymphoid Tissue | 2 | 1994 | 21 | 0.130 |
Why?
|
| Immunotherapy, Active | 1 | 2015 | 3 | 0.130 |
Why?
|
| Oligopeptides | 1 | 1995 | 30 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2014 | 99 | 0.120 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 22 | 0.120 |
Why?
|
| Cloning, Molecular | 3 | 2005 | 35 | 0.120 |
Why?
|
| Oligosaccharides | 2 | 2012 | 25 | 0.120 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 105 | 0.120 |
Why?
|
| Biomarkers | 5 | 2011 | 733 | 0.120 |
Why?
|
| Polyethylenes | 4 | 2001 | 40 | 0.120 |
Why?
|
| Protein Binding | 3 | 2003 | 124 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2011 | 324 | 0.120 |
Why?
|
| Collagen Type II | 3 | 2003 | 33 | 0.120 |
Why?
|
| Extracellular Matrix | 5 | 2012 | 75 | 0.120 |
Why?
|
| Histones | 2 | 2013 | 28 | 0.120 |
Why?
|
| Chromatin | 1 | 2014 | 15 | 0.120 |
Why?
|
| Sheep | 2 | 2004 | 42 | 0.120 |
Why?
|
| Cell Membrane | 3 | 2002 | 106 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2013 | 18 | 0.110 |
Why?
|
| Interleukins | 2 | 2011 | 38 | 0.110 |
Why?
|
| Macrophages, Peritoneal | 1 | 1993 | 13 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2004 | 39 | 0.110 |
Why?
|
| Aurora Kinases | 1 | 2013 | 4 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 2 | 2012 | 400 | 0.110 |
Why?
|
| Biotransformation | 1 | 2013 | 8 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 46 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 9 | 0.110 |
Why?
|
| Immunodominant Epitopes | 1 | 2013 | 3 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 3 | 2019 | 15 | 0.110 |
Why?
|
| Transgenes | 2 | 2003 | 16 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 1993 | 55 | 0.110 |
Why?
|
| Chromosomes | 1 | 2012 | 2 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 57 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1990 | 45 | 0.110 |
Why?
|
| Receptors, Cytokine | 2 | 2013 | 4 | 0.100 |
Why?
|
| In Vitro Techniques | 3 | 2016 | 215 | 0.100 |
Why?
|
| Blotting, Northern | 3 | 2003 | 27 | 0.100 |
Why?
|
| Binding Sites | 3 | 2001 | 75 | 0.100 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 25 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 91 | 0.100 |
Why?
|
| Antirheumatic Agents | 1 | 2013 | 93 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 32 | 0.100 |
Why?
|
| Alleles | 1 | 2012 | 236 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 34 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 60 | 0.100 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2012 | 2 | 0.100 |
Why?
|
| Isoxazoles | 1 | 1992 | 17 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2019 | 30 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 42 | 0.100 |
Why?
|
| Gene Dosage | 1 | 2012 | 25 | 0.100 |
Why?
|
| Rheumatoid Factor | 2 | 2011 | 9 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 36 | 0.100 |
Why?
|
| Uveitis | 1 | 2012 | 11 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 318 | 0.100 |
Why?
|
| Alpha-Globulins | 3 | 2012 | 7 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 31 | 0.100 |
Why?
|
| Lymphopenia | 1 | 2011 | 6 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 6 | 0.100 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 4 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2011 | 13 | 0.100 |
Why?
|
| Leukocyte Rolling | 2 | 2008 | 4 | 0.100 |
Why?
|
| Synovitis | 3 | 2006 | 23 | 0.100 |
Why?
|
| Tryptases | 1 | 2011 | 7 | 0.100 |
Why?
|
| Genotype | 4 | 2005 | 428 | 0.100 |
Why?
|
| Heparin | 1 | 2011 | 25 | 0.090 |
Why?
|
| Drug Synergism | 4 | 2004 | 66 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 5 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 2 | 1990 | 11 | 0.090 |
Why?
|
| Animals, Newborn | 4 | 2002 | 59 | 0.090 |
Why?
|
| Temporomandibular Joint | 1 | 2011 | 12 | 0.090 |
Why?
|
| Chromium | 3 | 2005 | 93 | 0.090 |
Why?
|
| Oocytes | 2 | 2003 | 15 | 0.090 |
Why?
|
| Versicans | 2 | 2003 | 17 | 0.090 |
Why?
|
| Antigens, Differentiation | 2 | 2004 | 20 | 0.090 |
Why?
|
| Chondrocytes | 2 | 2002 | 208 | 0.090 |
Why?
|
| Calcium | 4 | 1997 | 503 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2010 | 13 | 0.090 |
Why?
|
| Heterozygote | 1 | 2011 | 107 | 0.090 |
Why?
|
| Macrophage Activation | 1 | 2010 | 13 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2000 | 113 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 108 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 44 | 0.090 |
Why?
|
| Femoral Neoplasms | 1 | 1990 | 4 | 0.090 |
Why?
|
| Caspase 3 | 2 | 2019 | 30 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 1990 | 46 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1990 | 15 | 0.090 |
Why?
|
| HLA-B27 Antigen | 1 | 2009 | 2 | 0.090 |
Why?
|
| Nerve Net | 1 | 2010 | 51 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 1990 | 55 | 0.090 |
Why?
|
| Chondrosarcoma | 1 | 1990 | 37 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2003 | 124 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 442 | 0.080 |
Why?
|
| Clone Cells | 3 | 2003 | 22 | 0.080 |
Why?
|
| Binding, Competitive | 2 | 2016 | 28 | 0.080 |
Why?
|
| Glycosylation | 3 | 2003 | 24 | 0.080 |
Why?
|
| Peritoneal Lavage | 1 | 2009 | 2 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2009 | 9 | 0.080 |
Why?
|
| Peritoneum | 1 | 2009 | 18 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2011 | 532 | 0.080 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2009 | 1 | 0.080 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2009 | 8 | 0.080 |
Why?
|
| Receptors, Chemokine | 1 | 2008 | 12 | 0.080 |
Why?
|
| Anterior Chamber | 1 | 2008 | 2 | 0.080 |
Why?
|
| Indomethacin | 2 | 2001 | 8 | 0.080 |
Why?
|
| Models, Animal | 2 | 2005 | 130 | 0.070 |
Why?
|
| Bone and Bones | 3 | 1987 | 126 | 0.070 |
Why?
|
| Neurons | 1 | 2010 | 378 | 0.070 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2007 | 5 | 0.070 |
Why?
|
| Tryptophan | 1 | 2007 | 13 | 0.070 |
Why?
|
| Cell Adhesion | 5 | 2008 | 46 | 0.070 |
Why?
|
| Radiography | 2 | 2005 | 695 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2006 | 22 | 0.070 |
Why?
|
| Inbreeding | 1 | 2006 | 3 | 0.070 |
Why?
|
| Cartilage Diseases | 2 | 1993 | 90 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2006 | 27 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 81 | 0.070 |
Why?
|
| Chemokine CCL2 | 2 | 2006 | 24 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 272 | 0.070 |
Why?
|
| Alloys | 2 | 1997 | 94 | 0.070 |
Why?
|
| Genome, Human | 1 | 2006 | 50 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 1986 | 3 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1505 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 19 | 0.070 |
Why?
|
| Microscopy, Video | 1 | 2005 | 5 | 0.070 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2005 | 6 | 0.060 |
Why?
|
| Knee Joint | 2 | 2002 | 826 | 0.060 |
Why?
|
| Hybridization, Genetic | 1 | 2005 | 3 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 36 | 0.060 |
Why?
|
| Ankle Joint | 1 | 2005 | 41 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 1997 | 29 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2002 | 9 | 0.060 |
Why?
|
| Protein Precursors | 2 | 2016 | 20 | 0.060 |
Why?
|
| Transcription Factor RelA | 2 | 2005 | 14 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2003 | 40 | 0.060 |
Why?
|
| Young Adult | 1 | 2011 | 2063 | 0.060 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2003 | 4 | 0.060 |
Why?
|
| Fas Ligand Protein | 2 | 2003 | 9 | 0.060 |
Why?
|
| Fibronectins | 1 | 1985 | 33 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 1996 | 168 | 0.060 |
Why?
|
| Osteonectin | 1 | 2004 | 5 | 0.060 |
Why?
|
| Calcification, Physiologic | 2 | 2003 | 21 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2003 | 36 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 20 | 0.060 |
Why?
|
| Surface Properties | 2 | 1995 | 133 | 0.060 |
Why?
|
| Decorin | 3 | 2003 | 17 | 0.060 |
Why?
|
| Biglycan | 3 | 2003 | 17 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 7 | 1990 | 78 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2004 | 37 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2004 | 29 | 0.060 |
Why?
|
| Transfection | 2 | 2001 | 126 | 0.060 |
Why?
|
| Complementarity Determining Regions | 1 | 2003 | 2 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 27 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2003 | 9 | 0.060 |
Why?
|
| Acetylglucosaminidase | 1 | 2003 | 5 | 0.060 |
Why?
|
| Glucuronidase | 1 | 2003 | 11 | 0.060 |
Why?
|
| Lod Score | 1 | 2003 | 22 | 0.060 |
Why?
|
| X Chromosome | 1 | 2003 | 9 | 0.060 |
Why?
|
| Neurocan | 1 | 2003 | 1 | 0.060 |
Why?
|
| Brevican | 1 | 2003 | 1 | 0.060 |
Why?
|
| Infertility, Female | 1 | 2003 | 13 | 0.050 |
Why?
|
| Thymectomy | 2 | 1975 | 2 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2003 | 38 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2003 | 3 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2003 | 19 | 0.050 |
Why?
|
| Rabbits | 7 | 1982 | 286 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 91 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2003 | 63 | 0.050 |
Why?
|
| Toes | 1 | 2002 | 8 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 13 | 0.050 |
Why?
|
| Self Tolerance | 1 | 2002 | 2 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2002 | 14 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 31 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 3 | 2001 | 8 | 0.050 |
Why?
|
| Cell Separation | 2 | 2016 | 43 | 0.050 |
Why?
|
| Isoantigens | 1 | 2002 | 7 | 0.050 |
Why?
|
| Peritonitis | 1 | 2002 | 19 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2002 | 26 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2002 | 37 | 0.050 |
Why?
|
| Receptors, Concanavalin A | 1 | 1982 | 1 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2002 | 13 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2005 | 16 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2002 | 32 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2002 | 20 | 0.050 |
Why?
|
| Ovary | 2 | 2003 | 19 | 0.050 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 13 | 0.050 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2002 | 2 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cation Transport Proteins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Tyrosine | 1 | 2002 | 26 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 175 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 13 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 95 | 0.050 |
Why?
|
| Preventive Medicine | 1 | 2001 | 12 | 0.050 |
Why?
|
| Transplantation, Heterologous | 3 | 1990 | 20 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2013 | 320 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2001 | 1 | 0.050 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 1 | 2001 | 1 | 0.050 |
Why?
|
| Metalloendopeptidases | 3 | 1997 | 25 | 0.050 |
Why?
|
| Sex Factors | 1 | 2003 | 511 | 0.050 |
Why?
|
| Cobalt | 2 | 2005 | 113 | 0.050 |
Why?
|
| Receptors, Interleukin | 2 | 2013 | 5 | 0.050 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2001 | 6 | 0.050 |
Why?
|
| Plastics | 1 | 2001 | 1 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2001 | 37 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2000 | 6 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 7 | 0.050 |
Why?
|
| Corrosion | 2 | 2001 | 133 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2001 | 35 | 0.050 |
Why?
|
| Caspases | 1 | 2000 | 33 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2000 | 17 | 0.050 |
Why?
|
| Fibromodulin | 2 | 2003 | 15 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 4 | 0.050 |
Why?
|
| Immunochemistry | 3 | 1995 | 5 | 0.050 |
Why?
|
| Reference Values | 2 | 1998 | 229 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 143 | 0.040 |
Why?
|
| Polymers | 1 | 2000 | 42 | 0.040 |
Why?
|
| Regeneration | 4 | 1980 | 27 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1997 | 45 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2020 | 12 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 1990 | 23 | 0.040 |
Why?
|
| Genes, MHC Class II | 1 | 1999 | 3 | 0.040 |
Why?
|
| Carbohydrates | 2 | 2012 | 14 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 1999 | 5 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1999 | 7 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1999 | 8 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2000 | 191 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 1999 | 7 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2001 | 341 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 19 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 7 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2019 | 9 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2019 | 15 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2019 | 24 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2001 | 698 | 0.040 |
Why?
|
| Thymosin | 2 | 1979 | 2 | 0.040 |
Why?
|
| Thymus Hormones | 2 | 1979 | 2 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2014 | 49 | 0.040 |
Why?
|
| Pentosephosphates | 1 | 1979 | 1 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 275 | 0.040 |
Why?
|
| Diterpenes | 1 | 2018 | 9 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2018 | 20 | 0.040 |
Why?
|
| Ankle | 1 | 2018 | 17 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 105 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 1995 | 9 | 0.040 |
Why?
|
| Stimulation, Chemical | 2 | 1995 | 13 | 0.040 |
Why?
|
| Carbohydrate Sequence | 1 | 1998 | 15 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 132 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 1979 | 76 | 0.040 |
Why?
|
| Transcription Factors | 1 | 1999 | 172 | 0.040 |
Why?
|
| Introns | 1 | 1997 | 16 | 0.040 |
Why?
|
| Lectins | 1 | 1997 | 4 | 0.040 |
Why?
|
| Prednisolone | 1 | 2017 | 9 | 0.040 |
Why?
|
| Etanercept | 1 | 2017 | 23 | 0.040 |
Why?
|
| Fibrinolysin | 2 | 2011 | 5 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2017 | 3806 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1994 | 75 | 0.040 |
Why?
|
| Adolescent | 2 | 1998 | 2401 | 0.040 |
Why?
|
| DNA Primers | 1 | 1996 | 53 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 225 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 246 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2005 | 860 | 0.030 |
Why?
|
| Mice, Nude | 2 | 1995 | 36 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 24 | 0.030 |
Why?
|
| Enkephalins | 1 | 2016 | 2 | 0.030 |
Why?
|
| Materials Testing | 1 | 1997 | 134 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 10 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 19 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 118 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 29 | 0.030 |
Why?
|
| Electron Probe Microanalysis | 1 | 1995 | 3 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 1995 | 7 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 70 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1993 | 15 | 0.030 |
Why?
|
| Chickens | 1 | 1995 | 32 | 0.030 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1995 | 4 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1995 | 15 | 0.030 |
Why?
|
| Chloroquine | 1 | 1995 | 12 | 0.030 |
Why?
|
| Biological Transport | 1 | 1995 | 44 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 43 | 0.030 |
Why?
|
| Spinal Fusion | 1 | 2003 | 562 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1995 | 13 | 0.030 |
Why?
|
| Temperature | 1 | 1995 | 74 | 0.030 |
Why?
|
| Connective Tissue | 1 | 1975 | 26 | 0.030 |
Why?
|
| Shwartzman Phenomenon | 1 | 1974 | 1 | 0.030 |
Why?
|
| Calcium Radioisotopes | 1 | 1994 | 3 | 0.030 |
Why?
|
| Prostaglandins E | 1 | 1994 | 4 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1994 | 24 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 37 | 0.030 |
Why?
|
| Gene Library | 1 | 1994 | 8 | 0.030 |
Why?
|
| Bone Development | 1 | 1975 | 37 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 65 | 0.030 |
Why?
|
| Immunotherapy | 1 | 1995 | 69 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 662 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 103 | 0.030 |
Why?
|
| Biological Factors | 1 | 2014 | 9 | 0.030 |
Why?
|
| Autografts | 1 | 2014 | 35 | 0.030 |
Why?
|
| Thymus Extracts | 1 | 1973 | 1 | 0.030 |
Why?
|
| Chondroitin Sulfates | 2 | 1987 | 30 | 0.030 |
Why?
|
| Litter Size | 1 | 1993 | 1 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 36 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1993 | 10 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Microspheres | 1 | 1994 | 40 | 0.030 |
Why?
|
| Fertility | 1 | 1993 | 19 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 1986 | 637 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1994 | 300 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1993 | 19 | 0.030 |
Why?
|
| Reoperation | 2 | 1995 | 950 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2013 | 20 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2013 | 9 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2013 | 21 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2013 | 29 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1993 | 25 | 0.030 |
Why?
|
| Chondrocalcinosis | 1 | 1993 | 5 | 0.030 |
Why?
|
| Blood Platelets | 2 | 2008 | 51 | 0.030 |
Why?
|
| Macromolecular Substances | 3 | 1997 | 17 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2012 | 1 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2012 | 6 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 429 | 0.030 |
Why?
|
| Lactation | 1 | 1993 | 63 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2012 | 15 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2012 | 17 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 60 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 2008 | 93 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 818 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2012 | 22 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2012 | 4 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2012 | 23 | 0.030 |
Why?
|
| Transcriptome | 1 | 2013 | 89 | 0.030 |
Why?
|
| Lipopeptides | 1 | 2012 | 12 | 0.030 |
Why?
|
| Joint Instability | 1 | 1997 | 405 | 0.030 |
Why?
|
| Histocytochemistry | 5 | 1982 | 26 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2012 | 84 | 0.030 |
Why?
|
| Smoking | 1 | 2013 | 197 | 0.030 |
Why?
|
| Pregnancy | 1 | 1993 | 404 | 0.030 |
Why?
|
| Movement | 1 | 1993 | 137 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2012 | 97 | 0.030 |
Why?
|
| Eye | 1 | 2012 | 12 | 0.030 |
Why?
|
| Rheumatology | 1 | 2013 | 90 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 133 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2012 | 66 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 330 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 13 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 37 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 2010 | 1 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2010 | 7 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1983 | 75 | 0.020 |
Why?
|
| Spondylitis | 1 | 1990 | 3 | 0.020 |
Why?
|
| Darkness | 1 | 2010 | 18 | 0.020 |
Why?
|
| Axons | 1 | 2010 | 37 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 9 | 0.020 |
Why?
|
| Sphingosine | 1 | 2010 | 4 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2010 | 4 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 1990 | 2 | 0.020 |
Why?
|
| Visual Perception | 1 | 2010 | 48 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1990 | 3 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 3 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 24 | 0.020 |
Why?
|
| Amino Acids | 2 | 1987 | 22 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2010 | 88 | 0.020 |
Why?
|
| Mycobacteriaceae | 1 | 2009 | 1 | 0.020 |
Why?
|
| Hip Joint | 1 | 1994 | 406 | 0.020 |
Why?
|
| Gait | 1 | 1993 | 407 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 468 | 0.020 |
Why?
|
| Age Factors | 2 | 1986 | 873 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1979 | 19 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 1991 | 41 | 0.020 |
Why?
|
| Femur | 2 | 1971 | 402 | 0.020 |
Why?
|
| Peptidoglycan | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 28 | 0.020 |
Why?
|
| Immunodiffusion | 3 | 1979 | 3 | 0.020 |
Why?
|
| Immunoelectrophoresis | 3 | 1979 | 4 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 1968 | 46 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2001 | 91 | 0.020 |
Why?
|
| Immune Sera | 2 | 1986 | 9 | 0.020 |
Why?
|
| Kynuramine | 1 | 2007 | 2 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1987 | 55 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 37 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 15 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 48 | 0.020 |
Why?
|
| Wound Healing | 1 | 1968 | 174 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1986 | 9 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2006 | 6 | 0.020 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2006 | 7 | 0.020 |
Why?
|
| Borohydrides | 1 | 1986 | 2 | 0.020 |
Why?
|
| Alkalies | 1 | 1986 | 3 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 26 | 0.020 |
Why?
|
| Larynx | 1 | 1986 | 15 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2005 | 4 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2005 | 16 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2005 | 8 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 15 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2005 | 1 | 0.020 |
Why?
|
| Lymphocyte Cooperation | 1 | 2005 | 2 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 19 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 38 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1985 | 20 | 0.020 |
Why?
|
| Abatacept | 1 | 2004 | 8 | 0.020 |
Why?
|
| Nickel | 1 | 2005 | 31 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 12 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2004 | 16 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2004 | 6 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 2004 | 10 | 0.020 |
Why?
|
| Granulation Tissue | 2 | 1979 | 2 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 2004 | 8 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2005 | 47 | 0.010 |
Why?
|
| Cell Communication | 1 | 2004 | 29 | 0.010 |
Why?
|
| Infant | 1 | 1986 | 578 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1986 | 689 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 65 | 0.010 |
Why?
|
| Autoradiography | 1 | 2003 | 11 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 28 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2003 | 21 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2003 | 11 | 0.010 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1983 | 4 | 0.010 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 1983 | 6 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 260 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 1922 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 2002 | 3 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2002 | 3 | 0.010 |
Why?
|
| Superantigens | 1 | 2002 | 3 | 0.010 |
Why?
|
| CD11b Antigen | 1 | 2002 | 18 | 0.010 |
Why?
|
| Enterotoxins | 1 | 2002 | 5 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 35 | 0.010 |
Why?
|
| Copper-transporting ATPases | 1 | 2002 | 1 | 0.010 |
Why?
|
| Hungary | 1 | 2002 | 1 | 0.010 |
Why?
|
| Ribs | 1 | 1982 | 18 | 0.010 |
Why?
|
| Cell Migration Inhibition | 2 | 1979 | 4 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 18 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1982 | 8 | 0.010 |
Why?
|
| Osteochondritis | 1 | 1982 | 4 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 73 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 60 | 0.010 |
Why?
|
| Haplotypes | 1 | 2002 | 64 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 549 | 0.010 |
Why?
|
| Child | 1 | 1986 | 1430 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2001 | 10 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1994 | 15 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 1979 | 2 | 0.010 |
Why?
|
| Phosphogluconate Dehydrogenase | 2 | 1979 | 2 | 0.010 |
Why?
|
| Glucose | 1 | 2001 | 65 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2003 | 281 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1987 | 523 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2000 | 6 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2000 | 8 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 1801 | 0.010 |
Why?
|
| Actins | 1 | 2000 | 46 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2000 | 52 | 0.010 |
Why?
|
| Hydrolases | 1 | 1980 | 5 | 0.010 |
Why?
|
| Lysosomes | 1 | 1980 | 26 | 0.010 |
Why?
|
| Knee | 1 | 1980 | 47 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1979 | 4 | 0.010 |
Why?
|
| Hexoses | 1 | 1979 | 2 | 0.010 |
Why?
|
| Skin Tests | 1 | 1979 | 13 | 0.010 |
Why?
|
| Tibia | 2 | 1991 | 274 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1997 | 2 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1997 | 12 | 0.010 |
Why?
|
| Lung | 2 | 1978 | 173 | 0.010 |
Why?
|
| Serine | 1 | 1997 | 11 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1997 | 37 | 0.010 |
Why?
|
| Endothelium | 1 | 1997 | 14 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 27 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1975 | 4 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1975 | 5 | 0.010 |
Why?
|
| Glycogen | 1 | 1975 | 18 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 1974 | 2 | 0.010 |
Why?
|
| Polymyxins | 1 | 1974 | 2 | 0.010 |
Why?
|
| Colicins | 1 | 1974 | 5 | 0.010 |
Why?
|
| Thrombocytosis | 1 | 1974 | 3 | 0.010 |
Why?
|
| Protamines | 1 | 1974 | 6 | 0.010 |
Why?
|
| Aorta | 1 | 1975 | 28 | 0.010 |
Why?
|
| Bronchi | 1 | 1974 | 13 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1974 | 17 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1974 | 9 | 0.010 |
Why?
|
| Lipids | 1 | 1975 | 38 | 0.010 |
Why?
|
| Endotoxins | 1 | 1974 | 28 | 0.010 |
Why?
|
| Calcinosis | 1 | 1975 | 50 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1974 | 62 | 0.010 |
Why?
|
| Osteonecrosis | 1 | 1994 | 19 | 0.010 |
Why?
|
| Cementation | 1 | 1994 | 33 | 0.010 |
Why?
|
| Epithelium | 1 | 1973 | 29 | 0.010 |
Why?
|
| Immunoassay | 1 | 1973 | 45 | 0.010 |
Why?
|
| Hexosephosphates | 1 | 1973 | 1 | 0.010 |
Why?
|
| Kidney | 1 | 1974 | 181 | 0.010 |
Why?
|
| Tendons | 1 | 1975 | 229 | 0.010 |
Why?
|
| Sepharose | 1 | 1991 | 5 | 0.010 |
Why?
|
| Tissue Embedding | 1 | 1991 | 5 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 1991 | 11 | 0.010 |
Why?
|
| Sarcoma | 1 | 1994 | 149 | 0.010 |
Why?
|
| Epiphyses | 1 | 1971 | 14 | 0.010 |
Why?
|
| Pepsin A | 1 | 1990 | 2 | 0.010 |
Why?
|
| Radius | 1 | 1971 | 32 | 0.010 |
Why?
|
| Growth Plate | 1 | 1990 | 24 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1990 | 17 | 0.010 |
Why?
|
| Humerus | 1 | 1971 | 103 | 0.010 |
Why?
|
| Propidium | 1 | 1990 | 4 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1971 | 59 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1988 | 17 | 0.000 |
Why?
|
| Ciliary Body | 1 | 1968 | 1 | 0.000 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 1968 | 6 | 0.000 |
Why?
|
| Galactosamine | 1 | 1987 | 1 | 0.000 |
Why?
|
| Uronic Acids | 1 | 1987 | 1 | 0.000 |
Why?
|
| Biomarkers, Tumor | 1 | 1990 | 217 | 0.000 |
Why?
|
| Glucosamine | 1 | 1987 | 9 | 0.000 |
Why?
|
| Hemostatics | 1 | 1968 | 12 | 0.000 |
Why?
|
| Urinary Bladder | 1 | 1968 | 21 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1987 | 12 | 0.000 |
Why?
|
| Electron Transport Complex IV | 2 | 1980 | 5 | 0.000 |
Why?
|
| Succinate Dehydrogenase | 2 | 1980 | 3 | 0.000 |
Why?
|
| Cyanides | 1 | 1980 | 1 | 0.000 |
Why?
|
| Monoamine Oxidase | 1 | 1980 | 1 | 0.000 |
Why?
|
| Xanthine Oxidase | 1 | 1980 | 3 | 0.000 |
Why?
|
| Catalase | 1 | 1980 | 7 | 0.000 |
Why?
|
| Peroxidases | 1 | 1980 | 8 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1980 | 51 | 0.000 |
Why?
|
| Phenols | 1 | 1978 | 8 | 0.000 |
Why?
|
| Oxidoreductases | 1 | 1978 | 11 | 0.000 |
Why?
|
| Blood Cells | 1 | 1978 | 6 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1978 | 51 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1978 | 34 | 0.000 |
Why?
|
| Liver | 1 | 1978 | 184 | 0.000 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1975 | 1 | 0.000 |
Why?
|
| Fructose-Bisphosphatase | 1 | 1975 | 1 | 0.000 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 1975 | 1 | 0.000 |
Why?
|
| Aconitate Hydratase | 1 | 1973 | 1 | 0.000 |
Why?
|
| Glutamate Dehydrogenase | 1 | 1973 | 1 | 0.000 |
Why?
|
| Malate Dehydrogenase | 1 | 1973 | 1 | 0.000 |
Why?
|
| Citric Acid Cycle | 1 | 1973 | 2 | 0.000 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 1973 | 2 | 0.000 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 1973 | 2 | 0.000 |
Why?
|
| Tetrazolium Salts | 1 | 1973 | 3 | 0.000 |
Why?
|
| Glutathione Reductase | 1 | 1973 | 5 | 0.000 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 1973 | 3 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1973 | 72 | 0.000 |
Why?
|
| Macroglobulins | 1 | 1972 | 1 | 0.000 |
Why?
|
| Fluorescence | 1 | 1972 | 12 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1972 | 22 | 0.000 |
Why?
|